• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
44.11
1090.02
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.05
 

xl energy ltd
Lokesh Machines hits the roof after securing Rs 58-cr defence order
Jul 16,2026
The contract involves the supply of modification (MOD) kits for 7.62 mm medium machine guns.

The company clarified that the order does not constitute a related-party transaction and that neither its promoters nor members of the promoter group have any interest in the award of the contract.

Lokesh Machines is engaged in the business of manufacturing special purpose machines (SPM), general purpose machines/CNC lathes (GPM), connecting rods, and machining cylinder blocks and heads.

On a standalone basis, Lokesh Machines reported a sharp increase in net profit to Rs 2.15 crore in Q4 FY26 from Rs 0.13 crore in the corresponding quarter last year. Revenue from operations surged 53.4% year on year to Rs 59.36 crore during the quarter ended 31 March 2026.